1 | Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study | Srdan Verstovsek,Aaron T Gerds,Alessandro M Vannucchi,Haifa Kathrin Al-Ali,David Lavie,Andrew T Kuykendall,Sebastian Grosicki |